27-Hydroxycholesterol Induces Aberrant Morphology and Synaptic Dysfunction in Hippocampal Neurons
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Hypercholesterolemia is a risk factor for neurodegenerative diseases, but how high blood cholesterol levels are linked to neurodegeneration is still unknown. Here, we show that an excess of the blood-brain barrier permeable cholesterol metabolite 27-hydroxycholesterol (27-OH) impairs neuronal morphology and reduces hippocampal spine density and the levels of the postsynaptic protein PSD95. Dendritic spines are the main postsynaptic elements of excitatory synapses and are crucial structures for memory and cognition. Furthermore, PSD95 has an essential function for synaptic maintenance and plasticity. PSD95 synthesis is controlled by the REST-miR124a-PTBP1 axis. Here, we report that high levels of 27-OH induce REST-miR124a-PTBP1 axis dysregulation in a possible RxRγ-dependent manner, suggesting that 27-OH reduces PSD95 levels through this mechanism. Our results reveal a possible molecular link between hypercholesterolemia and neurodegeneration. We discuss the possibility that reduction of 27-OH levels could be a useful strategy for preventing memory and cognitive decline in neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Pyramidal neurons: dendritic structure and synaptic integration
Spruston, N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2286 · Cited by 1,688
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
PSD-95 Involvement in Maturation of Excitatory Synapses
El-Husseini, A. E.-D., Schnell, E., Chetkovich, D. M., Nicoll, R. A., & Bredt, D. S. (2000) · Science · doi:10.1126/science.290.5495.1364 · Cited by 1,303 · cited 2×
“2009) and for proper synaptic function and maintenance of synaptic connections (El-Husseini et al. 2000).”
(2006) · doi:10.1093/acprof:oso/9780195100273.001.0001 · Cited by 1,186 · cited 1×
“Indeed, CA pyramidal cells receive inputs from entorhinal cortex, CA3 pyramidal cells, thalamus, amygdala, and neuromodulatory inputs from a number of subcortical nuclei (Andersen et al. 2007).”
London, M., & Häusser, M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135703 · Cited by 1,149 · cited 1×
“Moreover, the complexity of dendritic structures in large part determines the biophysical properties, which influence their functional capacity (Koch et al. 1982; London and Hausser 2005; van Elburg and van Ooyen 2010).”
Brain Cholesterol: Long Secret Life Behind a Barrier
Björkhem, I., & Meaney, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000120374.59826.1b · Cited by 1,044 · cited 5×
“Some statins can cross the BBB, and therefore reduce the levels of cholesterol in the brain.”
InfluentialA microRNA array reveals extensive regulation of microRNAs during brain development
KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040 · cited 1×
“MiR-9 is one of the most abundant miRNAs in the brain, and has been shown to be a potent inducer of dendritic growth through the downregulation of REST (Lagos-Quintana et al. 2002; Krichevsky et al. 2003; Giusti et al. 2014).”
DeFelipe, J., & Fariñas, I. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90015-7 · Cited by 975
Self-citationReciprocal actions of REST and a microRNA promote neuronal identity
Conaco, C., Otto, S., Han, J.-J., & Mandel, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511041103 · Cited by 736 · cited 1×
“MiR-124a was shown to inhibit REST synthesis through a complex autoregulatory loop during neuronal differentiation (Ballas et al. 2005; Conaco et al. 2006).”
Boutz, P. L., Stoilov, P., Li, Q., Lin, C.-H., Chawla, G., Ostrow, K., Shiue, L., Ares, M., & Black, D. L. (2007) · Genes & Development · doi:10.1101/gad.1558107 · Cited by 577
Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits
Xue, Y., Ouyang, K., Huang, J., Zhou, Y., Ouyang, H., Li, H., Wang, G., Wu, Q., Wei, C., Bi, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2012.11.045 · Cited by 562 · cited 1×
“MiR-124a also inhibits PTBP1, turning the REST-PTBP1 negative feedback loop into a positive one (Xue et al. 2013).”
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
PSD-95 is required for activity-driven synapse stabilization.
Ehrlich, I., Klein, M., Rumpel, S., & Malinow, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609307104 · Cited by 470
Cholesterol in brain disease: Sometimes determinant and frequently implicated
Martín, M. G., Pfrieger, F., & Dotti, C. G. (2014) · The EMBO Reports · doi:10.15252/embr.201439225 · Cited by 304 · cited 1×
“It has been shown that cholesterol is an important player in the plasticity and synaptic function in the brain (Martin et al. 2014) as well as in the activation and AMPAR synaptic delivery during LTP (Brachet et al.”
MicroRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision
Johnston, R. J., Chang, S., Etchberger, J. F., Ortiz, C. O., & Hobert, O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505530102 · Cited by 276
PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2
Zheng, S., Gray, E. E., Chawla, G., Porse, B. T., O'Dell, T. J., & Black, D. L. (2012) · Nature Neuroscience · doi:10.1038/nn.3026 · Cited by 254 · cited 3×
“When PTBP1 levels increase, they regulate the splicing of PSD95 to a nonsense-mediated mRNA decay process (Zheng et al. 2012).”
InfluentialMass of the postsynaptic density and enumeration of three key molecules
Chen, X., Vinade, L., Leapman, R. D., Petersen, J. D., Nakagawa, T., Phillips, T. M., Sheng, M., & Reese, T. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505359102 · Cited by 236
Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M., & Lawrence, C. B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.010 · Cited by 232 · cited 1×
“Hypercholesterolemia in middle age is considered a risk factor for the development of AD and dementia (Kivipelto et al. 2001; Pancani et al. 2013; Knight et al. 2014).”
MicroRNAs in Neurodegenerative Diseases
(2017) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.04.002 · Cited by 168 · cited 1×
“MicroRNAs are considered key mediators in feedback regulatory networks, and their potential role on the pathogenesis behind neurodegenerative diseases has gained increasing attention (Johnston et al. 2005; Boutz et al. 2007; Eacker et al. 2009; Leung and Sharp 2013; Quinlan et al. 2017).”
Self-citationSooksawate, T., & Simmonds, M. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00159-3 · Cited by 153
Merino-Serrais, P., Benavides-Piccione, R., Blazquez-Llorca, L., Kastanauskaite, A., Rábano, A., Avila, J., & DeFelipe, J. (2013) · Brain · doi:10.1093/brain/awt088 · Cited by 134 · cited 1×
“Alterations on dendritic spines morphology have been described in relation with AD pathology and other neurodegenerative diseases (Knafo et al. 2009; Jimenez-Mateos et al. 2012; Merino-Serrais et al. 2013).”
Self-citationWidespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., & DeFelipe, J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn111 · Cited by 132
Self-citationMicroRNA-9 controls dendritic development by targeting REST
Giusti, S. A., Vogl, A. M., Brockmann, M. M., Vercelli, C. A., Rein, M. L., Trümbach, D., Wurst, W., Cazalla, D., Stein, V., Deussing, J. M., et al. (2014) · eLife · doi:10.7554/elife.02755 · Cited by 113 · cited 1×
“MiR-9 is one of the most abundant miRNAs in the brain, and has been shown to be a potent inducer of dendritic growth through the downregulation of REST (Lagos-Quintana et al. 2002; Krichevsky et al. 2003; Giusti et al. 2014).”
Bosch, C., Masachs, N., Exposito-Alonso, D., Martínez, A., Teixeira, C. M., Fernaud, I., Pujadas, L., Ulloa, F., Comella, J. X., DeFelipe, J., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw216 · Cited by 70
Self-citationAli, Z., Heverin, M., Olin, M., Acimovic, J., Lövgren-Sandblom, A., Shafaati, M., Båvner, A., Meiner, V., Leitersdorf, E., & Björkhem, I. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034124 · Cited by 54 · cited 3×
“OH has been proposed as a physiological inhibitor of cholesterol synthesis in the brain (Sever et al. 2003; Goldstein et al. 2006; Radhakrishnan et al. 2007; Ali et al. 2013), high levels of 27-”
Self-citationDo, H. T., Bruelle, C., Pham, D. D., Jauhiainen, M., Eriksson, O., Korhonen, L. T., & Lindholm, D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13397 · Cited by 37
Cited by
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Loera-Valencia, R., Goikolea, J., Parrado-Fernandez, C., Merino-Serrais, P., & Maioli, S. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.003 · Cited by 214
Self-citationImpaired cholesterol metabolism, neurons, and neuropsychiatric disorders
Cheon, S. Y. (2023) · Experimental Neurobiology · doi:10.5607/en23010 · Cited by 67
“In Cyp27 Transgenic (Tg) mice with high systemic expression of 27-hydrocholesterol, reduced spine density and dendritic arborisation were found in the hippocampus [50].”
BackgroundMethodInfluentialStaurenghi, E., Cerrato, V., Gamba, P., Testa, G., Giannelli, S., Leoni, V., Caccia, C., Buffo, A., Noble, W., Perez-Nievas, B. G., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101837 · Cited by 60
High levels of 27-hydroxycholesterol results in synaptic plasticity alterations in the hippocampus
Loera-Valencia, R., Vazquez-Juarez, E., Muñoz, A., Gerenu, G., Gómez-Galán, M., Lindskog, M., DeFelipe, J., Cedazo-Minguez, A., & Merino-Serrais, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83008-3 · Cited by 37
Self-citation
Metadata
- Authors
- Merino-Serrais, P., Loera-Valencia, R., Rodriguez-Rodriguez, P., Parrado-Fernandez, C., Ismail, M. A., Maioli, S., Matute, E., Jimenez-Mateos, E. M., Björkhem, I., DeFelipe, J., & Cedazo-Minguez, A.
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11-03
- Volume
- 29
- Issue
- 1
- Pages
- 429-446
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2899177904
- Cited by
- 70
- References
- 27
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.